We can’t show the full text here under this license. Use the link below to read it at the source.
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
How different fats in tiny particles affect vaccines and gene treatments
AI simplified
Abstract
Lipid nanoparticles (LNPs) are crucial for mRNA vaccines and nucleic acid therapies.
- LNPs contribute to mRNA vaccine efficacy and the delivery of nucleic acid-based therapies.
- The effectiveness of LNPs is influenced by their size, structure, stability, and encapsulation efficiency.
- Understanding the role of individual lipid components is essential for improving LNP performance.
- Challenges include assessing LNP delivery beyond the liver and evaluating immunogenicity.
- Strategies for overcoming these challenges may shape the future of LNP-based therapies.
AI simplified